High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: A matter of time?
作者信息
Barrasa Helena, Martín Alejandro, Maynar Javier, Rello Jordi, Fernández-Torres Marina, Aguirre-Quiñonero Amaia, Canut-Blasco Andrés
机构信息
Bioaraba, Intensive Care Unit, Vitoria-Gasteiz, Spain; Osakidetza Basque Health Service, Araba University Hospital, Intensive Care Unit, Vitoria-Gasteiz, Spain.
Bioaraba, Intensive Care Unit, Vitoria-Gasteiz, Spain; Osakidetza Basque Health Service, Araba University Hospital, Intensive Care Unit, Vitoria-Gasteiz, Spain.
出版信息
J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2020.12.001. Epub 2020 Dec 5.
Abstract
摘要
相似文献
1
High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: A matter of time?
J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2020.12.001. Epub 2020 Dec 5.
2
Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx).
Ultrasound Obstet Gynecol. 2021 Feb;57(2):224-231. doi: 10.1002/uog.23575.
3
Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.
J Korean Med Sci. 2021 May 24;36(20):e148. doi: 10.3346/jkms.2021.36.e148.
4
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection.
Infect Dis (Lond). 2020 Oct;52(10):698-704. doi: 10.1080/23744235.2020.1784457. Epub 2020 Jun 25.
5
Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia.
Curr Med Res Opin. 2021 Jan;37(1):21-25. doi: 10.1080/03007995.2020.1853510. Epub 2020 Dec 7.
6
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
7
Timing and causes of death in severe COVID-19 patients.
Crit Care. 2021 Jun 30;25(1):224. doi: 10.1186/s13054-021-03639-w.
8
Racial and Ethnic Disparities in Rates of COVID-19-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021.
JAMA Netw Open. 2021 Oct 1;4(10):e2130479. doi: 10.1001/jamanetworkopen.2021.30479.
9
Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.
J Infect Public Health. 2021 Oct;14(10):1381-1388. doi: 10.1016/j.jiph.2021.06.012. Epub 2021 Jun 25.
10
Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
PLoS Med. 2020 Sep 8;17(9):e1003308. doi: 10.1371/journal.pmed.1003308. eCollection 2020 Sep.
引用本文的文献
1
Determinants of COVID-19 severity and mortality in children: A retrospective and multicenter cohort study in Medan, Indonesia.
Narra J. 2024 Aug;4(2):e865. doi: 10.52225/narra.v4i2.865. Epub 2024 Aug 8.
2
Bacterial Community- and Hospital-Acquired Pneumonia in Patients with Critical COVID-19-A Prospective Monocentric Cohort Study.
Antibiotics (Basel). 2024 Feb 16;13(2):192. doi: 10.3390/antibiotics13020192.
3
Healthcare-associated infections in critical COVID-19 patients in Tunis: epidemiology, risk factors, and outcomes.
Acute Crit Care. 2023 Nov;38(4):425-434. doi: 10.4266/acc.2023.00773. Epub 2023 Nov 28.
4
A Systematic Review of Antimicrobial Resistance During the COVID-19 Pandemic.
Hawaii J Health Soc Welf. 2023 Aug;82(8):188-193.
5
Management of hypoxemia in SARS-CoV-2 infection: Lessons learned from one year of experience, with a special focus on silent hypoxemia.
J Intensive Med. 2021 Mar 9;1(1):26-30. doi: 10.1016/j.jointm.2021.02.001. eCollection 2021 Jul.
6
Value of syndromic panels in the management of severe community-acquired pneumonia.
Rev Esp Quimioter. 2022 Apr;35 Suppl 1(Suppl 1):15-20. doi: 10.37201/req/s01.03.2022. Epub 2022 Apr 22.
7
Coinfection and superinfection in SARS-CoV-2 pneumonia. Two underestimated threats. The need of empirical treatment under debate.
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Apr;40(4):155-157. doi: 10.1016/j.eimce.2022.02.011.
8
Health care-associated infections in patients with COVID-19 pneumonia in COVID critical care areas.
Med Intensiva (Engl Ed). 2022 Apr;46(4):221-223. doi: 10.1016/j.medine.2021.04.013.
9
Coinfection and superinfection in SARS-CoV-2 pneumonia. Two underestimated threats. The need of empirical treatment under debate.
Enferm Infecc Microbiol Clin. 2022 Apr;40(4):155-157. doi: 10.1016/j.eimc.2022.02.002. Epub 2022 Mar 1.
10
High Rates of Bacterial Pulmonary Co-Infections and Superinfections Identified by Multiplex PCR among Critically Ill COVID-19 Patients.
Microorganisms. 2021 Nov 30;9(12):2483. doi: 10.3390/microorganisms9122483.
本文引用的文献
1
Procalcitonin and secondary bacterial infections in COVID-19: association with disease severity and outcomes.
Acta Clin Belg. 2022 Apr;77(2):268-272. doi: 10.1080/17843286.2020.1824749. Epub 2020 Sep 23.
2
Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19.
J Infect. 2021 Feb;82(2):e20-e21. doi: 10.1016/j.jinf.2020.09.010. Epub 2020 Sep 19.
3
Bacterial and fungal superinfections in critically ill patients with COVID-19.
Intensive Care Med. 2020 Nov;46(11):2071-2074. doi: 10.1007/s00134-020-06219-8. Epub 2020 Sep 9.
4
Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU.
Ann Intensive Care. 2020 Sep 7;10(1):119. doi: 10.1186/s13613-020-00736-x.
5
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
Clin Microbiol Infect. 2021 Jan;27(1):83-88. doi: 10.1016/j.cmi.2020.07.041. Epub 2020 Jul 31.
6
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. doi: 10.1016/j.cmi.2020.07.016. Epub 2020 Jul 22.
7
Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis.
Crit Care. 2020 Jul 9;24(1):410. doi: 10.1186/s13054-020-03135-7.
8
Co-infections in people with COVID-19: a systematic review and meta-analysis.
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
9
SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria.
Anaesth Crit Care Pain Med. 2020 Oct;39(5):553-561. doi: 10.1016/j.accpm.2020.04.001. Epub 2020 Apr 9.
10
A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients.
Am J Respir Crit Care Med. 2012 Jul 1;186(1):56-64. doi: 10.1164/rccm.201111-1978OC. Epub 2012 Apr 19.
Zotero 插件